PharmGKB ID	Variant	Literature	Genes	Association	Significance	P-Value	# of Cases	# of Controls	Biogeographical Groups	Phenotype Categories	Pediatric	More Details	Molecules
699639217	rs6275	PMID:21047205	DRD2	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	not stated		155		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
699639221	rs1800497	PMID:21047205	ANKK1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	not stated		155		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
827793233	rs1360780	PMID:21449676	FKBP5	Allele T is associated with increased risk of suicidal ideation when treated with clomipramine, liothyronine, lithium, nefazodone, paroxetine or venlafaxine in people with Depression as compared to allele C.	yes	= 0.002	74		European	Other	false		clomipramine; liothyronine; lithium; nefazodone; paroxetine; venlafaxine
699639210	rs265981	PMID:21047205	DRD1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	not stated		155		European	Dosage	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
981954215	rs2769605	PMCID:PMC3658129		Genotype CC is associated with decreased response to lithium or valproic acid in people with Bipolar Disorder as compared to genotypes CT + TT.	yes	= 0.013	284		East Asian	Efficacy	false		lithium; valproic acid
827793270	rs130058	PMID:21449676	HTR1B	Allele A is associated with decreased risk of suicidal ideation when treated with clomipramine, liothyronine, lithium, nefazodone or venlafaxine in people with Depression as compared to allele T.	yes	= 0.008	74		European	Efficacy	false	Please note: here the alleles are reported on the plus strand, whereas in the study allele T was reported as the risk allele (the gene is on the minus strand). The opposite effect was found in patients treated with paroxetine.	clomipramine; liothyronine; lithium; nefazodone; venlafaxine
981953956	rs334558	PMID:23021822	GSK3B	Genotype AA is associated with decreased response when treated with lithium in people with Bipolar Disorder as compared to genotypes AG + GG.	yes	= 0.044	83	55	East Asian	Efficacy	false		lithium
981954223	rs1565445	PMCID:PMC3658129	NTRK2	Genotype AA is not associated with response to lithium or valproic acid in people with Bipolar Disorder as compared to genotypes AG + GG.	no	= 0.458	284		East Asian	Efficacy	false		lithium; valproic acid
699639199	rs4532	PMID:21047205	DRD1	Allele C is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		92		European	Efficacy	false	This is from a review article which does not give all the details.  It does not state exactly how the alleles were compared.	lithium
981953963	rs6438552	PMID:23021822	GSK3B	Genotype AA is not associated with decreased response when treated with lithium in people with Bipolar Disorder as compared to genotypes AG + GG.	no	= 0.104	83	55	East Asian	Efficacy	false	The differences in lithium treatment efficacy among different genotypes of rs6438552 was significant using uncorrected data (Kruskal - Wallis test) but did not remain significant after correction for the multiple testing with FDR (FDR-corrected P=0.104).	lithium
827793255	rs2032582	PMID:21449676	ABCB1	Allele A is associated with increased risk of suicidal ideation when treated with clomipramine, liothyronine, lithium, nefazodone, paroxetine or venlafaxine in people with Depression as compared to allele C.	yes	= 0.003	74		European	Other	false	Please note: alleles here are reported on the plus strand, whereas in the study allele T was reported as the risk allele compared to allele G.	clomipramine; liothyronine; lithium; nefazodone; paroxetine; venlafaxine
699639182	rs4680	PMID:21047205	COMT	Allele G is not associated with response to lithium in people with Bipolar Disorder as compared to allele A.	not stated		201		European	Efficacy	false	This is from a review article which does not give all the details.  It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
699639283	rs2433322	PMID:21047205	PDLIM5	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	not stated		155		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
827784981	rs6438552	PMCID:PMC3461952	GSK3B	Genotype GG is associated with increased response to lithium in people with Bipolar Disorder.	no		282		European	Efficacy	false	Authors say not significant.	lithium
699639287	rs1799913	PMID:21047205	TPH1	Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder.	not stated		108		European	Efficacy	false	This is from a review article which does not give all the details.	lithium
699639285	rs1800532	PMID:21047205	TPH1	Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder.	not stated		108		European	Efficacy	false	This is from a review article which does not give all the details	lithium
1447813645	rs78015114	PMCID:PMC4814312		Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	yes	= 1.31E-8	2563		Multiple groups, European, Asian, Other	Efficacy	false	"Patients had been taking lithium for at least 6 mo. Response to lithium was assayed using the Alda scale, which quantifies symptom improvement over time. The scale is from 0-10, with 10 being the highest response score and 0 being the lowest. The authors evaluated response using a dichotomous (=7 is ""responder"" and < 7 is ""non-responder"") and a continuous phenotype (0-10). This SNP was found to be associated with improved response to lithium using the continuous phenotype but not the dichotomous phenotype measure. The association was confirmed in an independent prospective study of 73 patients.  This is one of four SNPs in LD that show association (rs79663003, rs78015114, rs74795342, rs75222709)."	lithium
827784977	rs2071427	PMCID:PMC3461952	NR1D1; THRA	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	no		282		European	Efficacy	false	The authors describe this as a nominal association which did not survive correction for multiple testing.	lithium
827784991	rs6438552	PMCID:PMC3461952	GSK3B	Genotype GG is associated with increased response to lithium in people with Bipolar Disorder.	yes	< 0.0025	282		European	Efficacy	false	This result is for the combination of GG at this SNP with rs2071427 TT.  People with this genotype combination had a 75% chance of being in the Li-responsive group. People with rs2071427 CC/rs6438552 AA had a 44% response rate.  Those with 2 or 3 favorable alleles had responses on a gradient between these two results.	lithium
1447813633	rs79663003	PMCID:PMC4814312		Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	yes	= 1.37E-8	2563		Multiple groups, European, Asian, Other	Efficacy	false	"Patients had been taking lithium for at least 6 mo. Response to lithium was assayed using the Alda scale, which quantifies symptom improvement over time. The scale is from 0-10, with 10 being the highest response score and 0 being the lowest. The authors evaluated response using a dichotomous (=7 is ""responder"" and < 7 is ""non-responder"") and a continuous phenotype (0-10). This SNP was found to be associated with improved response to lithium using the continuous phenotype but not the dichotomous phenotype measure. The association was confirmed in an independent prospective study of 73 patients. This is one of four SNPs in LD that show association (rs79663003, rs78015114, rs74795342, rs75222709)."	lithium
827816731	rs4512905	PMID:21961650	SCN8A	Genotype TT is not associated with increased response to lithium in people with Bipolar Disorder as compared to genotype CC.	no	= 0.00564	204		Unknown	Efficacy	false	A trend was seen for an association but this did not reach statistical significance for quantitative trait analysis of long-term treatment response scale.	lithium
827784987	rs2071427	PMCID:PMC3461952	NR1D1; THRA	Genotype TT is associated with increased response to lithium in people with Bipolar Disorder.	yes		282		European	Efficacy	false	"This result is for the combination of this SNP with
rs6438552 GG.  People with this genotype combination had a 75% chance of being in the Li-responsive group.  People with rs2071427 CC/rs6438552 AA had a 44% response rate.  Those with 2 or 3 favorable alleles had responses on a gradient between these two results."	lithium
981954249	rs1387923	PMCID:PMC3658129	NTRK2	Genotype AA is not associated with response to lithium in people with Bipolar Disorder as compared to genotypes AG + GG.	no	= 0.796	284		East Asian	Efficacy	false		lithium
699639267	rs3755557	PMID:21047205	GSK3B	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		134		Multiple groups, Brazilian	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
1447813659	rs75222709	PMCID:PMC4814312		Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 3.50E-9	2563		Multiple groups, European, Asian, Other	Efficacy	false	"Patients had been taking lithium for at least 6 mo. Response to lithium was assayed using the Alda scale, which quantifies symptom improvement over time. The scale is from 0-10, with 10 being the highest response score and 0 being the lowest. The authors evaluated response using a dichotomous (=7 is ""responder"" and < 7 is ""non-responder"") and a continuous phenotype (0-10). This SNP was found to be associated with improved response to lithium using the continuous phenotype but not the dichotomous phenotype measure. The association was confirmed in an independent prospective study of 73 patients. This is one of four SNPs in LD that show association (rs79663003, rs78015114, rs74795342, rs75222709)."	lithium
699639266	rs334558	PMID:21047205	GSK3B	Allele G is not associated with response to lithium in people with Bipolar Disorder as compared to allele A.	not stated		184		European	Efficacy	false	This is from a review article which does not give all the details. It says that in this population, no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
699639264	rs334558	PMID:21047205	GSK3B	Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	not stated		88		European	Efficacy	false	This is from a review article which does not give all the details. It does not state exactly how the alleles were compared.	lithium
699639271	rs1387923	PMID:21047205	NTRK2	Genotype AA is associated with increased response to lithium in people with Bipolar Disorder.	not stated		184		European	Efficacy	false	This is from a review article which does not give all the details. It does not state exactly how the alleles were compared.	lithium
981954002	rs2279287	PMCID:PMC3461952	ARNTL	Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	no	= 0.57	282		European	Efficacy	false		lithium
699639269	rs971363	PMID:21047205	IMPA2	Allele G is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		184		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
827816704	rs16909440	PMID:21961650	OR52E2	Genotype TT is associated with increased response to lithium in people with Bipolar Disorder as compared to genotype CC.	yes	= 5.51E-4	204		Unknown	Efficacy	false	Quantitative trait analysis of long-term treatment response scale comparing all three genotypes - CT was associated with response between CC and TT.	lithium
699639275	rs2289656	PMID:21047205	NTRK2	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	not stated		108		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
981954014	rs1982350	PMCID:PMC3461952	ARNTL	Allele A is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	no	= 0.86	282		European	Efficacy	false		lithium
699639273	rs1187326	PMID:21047205	NTRK2	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		108		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
827784973	rs8192440	PMCID:PMC3461952	CRY1	Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	no		282		European	Efficacy	false	The authors describe this as a nominal association which did not survive correction for multiple testing.	lithium
699639279	rs10008257	PMID:21047205		Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	not stated		155		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
981940187	rs6313	PMID:10758249	HTR2A	Allele A is not associated with treatment outcome when treated with lithium in people with Bipolar Disorder as compared to allele G.	no		102		Unknown	Efficacy	false	The following clinical variables and lithium outcome measures were measured: Pre- and on-lithium manic and depressive episodes (P=0.11 and 0.22); Pre- and on-lithium treatment frequency (P=0.86 and 0.98).	lithium
699639277	rs1187327	PMID:21047205	NTRK2	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		108		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
1447813652	rs74795342	PMCID:PMC4814312		Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	yes	= 3.31E-9	2563		Multiple groups, European, Asian, Other	Efficacy	false	"Patients had been taking lithium for at least 6 mo. Response to lithium was assayed using the Alda scale, which quantifies symptom improvement over time. The scale is from 0-10, with 10 being the highest response score and 0 being the lowest. The authors evaluated response using a dichotomous (=7 is ""responder"" and < 7 is ""non-responder"") and a continuous phenotype (0-10). This SNP was found to be associated with improved response to lithium using the continuous phenotype but not the dichotomous phenotype measure. The same alleles had a lower rate of relapse of symptoms in an independent prospective study of 73 patients. The AG genotype was also associated with a greater risk of relapse as compared to the GG genotype. This is one of four SNPs in LD that show association (rs79663003, rs78015114, rs74795342, rs75222709)."	lithium
981954279	rs3918242	PMID:21437990	MMP9	Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	no	= 0.551	109		European	Efficacy	false		lithium
981940197	rs6318	PMID:10758249	HTR2C	Allele C is not associated with treatment outcome when treated with lithium in people with Bipolar Disorder as compared to allele G.	no		102		Unknown	Efficacy	false	The following clinical variables and lithium outcome measures were measured: Pre- and on-lithium manic and depressive episodes (P=0.57 and 0.65); Pre- and on-lithium treatment frequency (P=0.78 and 0.53).	lithium
699639253	rs6917661	PMID:21047205	CNKSR3	Allele C is not associated with response to lithium in people with Bipolar Disorder.	not stated		101		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
699639257	rs7301408	PMID:21047205		Allele G is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		105		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
981954029	rs2278749	PMCID:PMC3461952	ARNTL	Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	no	= 0.47	282		European	Efficacy	false		lithium
699639262	rs890	PMID:21047205	GRIN2B	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	not stated		105		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
699639260	rs1019358	PMID:21047205	NBAS	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	not stated		105		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
699639235	rs6280	PMID:21047205	DRD3	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		155		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
981954037	rs1801260	PMCID:PMC3461952	CLOCK	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	no	= 0.75	282		European	Efficacy	false		lithium
827816749	rs2826494	PMID:21961650		Allele G is associated with response to lithium in people with Bipolar Disorder as compared to allele C.	no	= 0.0019	204		Unknown	Efficacy	false	Patients were characterized as full responders compared to partial/non long-term responders. Quantitative trait analysis of long-term treatment response scale showed a trend for better response with the GG genotype compared to CC but was not statistically significant for this test (p=0.018). Please note; alleles are as reported in the study - it is not clear whether these are for the plus chromosomal strand.	lithium
981954045	rs3736544	PMCID:PMC3461952	CLOCK	Allele A is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	no	= 0.1	282		European	Efficacy	false		lithium
699639240	rs706895	PMID:21047205	FYN	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		101		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
699639244	rs3730353	PMID:21047205	FYN	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	not stated		101		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
827816744	rs16973410	PMID:21961650		Genotype CC is associated with increased response to lithium in people with Bipolar Disorder as compared to genotypes CT + TT.	yes	= 3.42E-4	204		Unknown	Efficacy	false	Quantitative trait analysis of long-term treatment response scale comparing all three genotypes.	lithium
981954051	rs34897046	PMCID:PMC3461952	CLOCK	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	no	= 0.45	282		European	Efficacy	false		lithium
981419765	rs2284018	PMID:18408563	CACNG2	Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotypes CC + CT.	yes	= 0.036	170		European	Efficacy	false	This is significant in the second cohort listed but not in the first.	lithium
981502733	rs12941497	PMID:19818381	NR1D1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	no		199		European	Efficacy	false	Full responders were compared to partial/non-responders, and allele and genotype frequencies did not differ between groups.	lithium
981954058	rs2304672	PMCID:PMC3461952	PER2	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	no	= 0.1	282		European	Efficacy	false		lithium
827816646	rs1390913	PMID:21961650		Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	no	= 0.712	204		Unknown	Efficacy	false	Patients were characterized as full responders compared to partial/non long-term responders. Quantitative trait analysis of long-term treatment response scale showed a trend for better response with AA and AG genotypes compared to GG but was not statistically significant for this test (p=0.0334).	lithium
981502741	rs939347	PMID:19818381	NR1D1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	no		199		European	Efficacy	false	Full responders were compared to partial/non-responders, and allele and genotype frequencies did not differ between groups.	lithium
981954065	rs228729	PMCID:PMC3461952	PER3	Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	no	= 0.49	282		European	Efficacy	false		lithium
981954077	rs228642	PMCID:PMC3461952	PER3	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	no	= 0.58	282		European	Efficacy	false		lithium
981502748	rs9315885	PMID:19818381	DGKH	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	no		199		European	Efficacy	false	Full responders were compared to partial/non-responders, and allele and genotype frequencies did not differ between groups.	lithium
1449144256	rs7588746	PMCID:PMC5833535		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 6.33E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
981502756	rs1012053	PMID:19818381	DGKH	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele A.	no		199		European	Efficacy	false	Full responders were compared to partial/non-responders, and allele and genotype frequencies did not differ between groups.	lithium
981954083	rs228666	PMCID:PMC3461952	PER3	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	no	= 0.61	282		European	Efficacy	false		lithium
1449144262	rs3919583	PMCID:PMC5833535		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	yes	= 2.65E-4	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
699639316	rs2433320	PMID:21047205	PDLIM5	Allele A is not associated with response to lithium in people with Bipolar Disorder.	not stated		155		European	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
981750318	rs2314339	PMID:20348464	NR1D1; THRA	Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	yes	< 0.05	160		European	Efficacy	false	Authors note that the comparison by genotype(CT+TT vs CC) rather than by allele was not significant after Bonferroni correction.  OR listed below is for non-improvement or worsening in carriers of the T allele.	lithium
981502763	rs1170191	PMID:19818381	DGKH	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	no		199		European	Efficacy	false	Full responders were compared to partial/non-responders, and allele and genotype frequencies did not differ between groups.	lithium
827816699	rs2499984	PMID:21961650	OR52J3	Genotype GG is associated with increased response to lithium in people with Bipolar Disorder as compared to genotype AA.	yes	= 8.7E-4	204		Unknown	Efficacy	false	Quantitative trait analysis of long-term treatment response scale comparing all three genotypes - GA was associated with response between GG and AA.	lithium
1449144268	rs1611255	PMCID:PMC5833535		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	yes	= 3.93E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false	Please note that this SNP is given the ID rs144373461 in the paper.	lithium
981954089	rs228697	PMCID:PMC3461952	PER3	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	no	= 0.66	282		European	Efficacy	false		lithium
827816679	rs2107506	PMID:21961650	LECT2	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	no	= 0.2208	204		Unknown	Efficacy	false	Please note: the LECT2 gene is found on the minus chromosomal strand - here we report alleles on the plus strand in a complementary manner from those reported in the study. Patients were characterized as full responders compared to partial/non long-term responders. Quantitative trait analysis of long-term treatment response scale comparing all three genotypes also found no statistical significant association.	lithium
981750325	rs4794826	PMID:20348464	NR1D1; THRA	Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	no		147		European	Efficacy	false		lithium
1449144274	rs209474	PMCID:PMC5833535		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 3.41E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
608431344	rs2284017	PMID:18408563	CACNG2	Allele C is associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	not stated	= 0.029	188		European	Efficacy	false		lithium
981954096	rs2859388	PMCID:PMC3461952	PER3	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	no	= 0.79	282		European	Efficacy	false		lithium
981750332	rs2071427	PMID:20348464	NR1D1; THRA	Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	no		140		European	Efficacy	false		lithium
1449144280	rs1521470	PMCID:PMC5833535	ADCY1	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 3.92E-4	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
1449144286	rs79403677	PMCID:PMC5833535	FAM177A1	Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 2.04E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
981954104	rs2640909	PMCID:PMC3461952	PER3	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	no	= 0.47	282		European	Efficacy	false		lithium
1449144225	rs7959663	PMCID:PMC5833535	MYO1H	Allele C is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 2.06E-4	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
981750338	rs2269457	PMID:20348464	NR1D1; THRA	Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	no		159		European	Efficacy	false		lithium
1449144231	rs66486766	PMCID:PMC5833535		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 4.95E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
699639163	rs1801260	PMID:21047205	CLOCK	Genotype GG is associated with increased risk of sleep disturbances when treated with lithium in people with Bipolar Disorder.	not stated		13		European	Toxicity	false	This is from a review article which does not give all the details.	lithium
981750351	rs12941497	PMID:20348464	NR1D1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	no		155		European	Efficacy	false		lithium
1449144238	rs7405404	PMCID:PMC5833535		Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	yes	= 5.27E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
699639139	rs6265	PMID:21047205	BDNF; BDNF-AS	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		161		East Asian	Efficacy	false	This is from a review article which does not give all the details. It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
981750357	rs939347	PMID:20348464	NR1D1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	no		149		European	Efficacy	false		lithium
1449144244	rs6728642	PMCID:PMC5833535	FAM178B	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 1.34E-4	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
981750364	rs2071570	PMID:20348464	NR1D1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	no		147		European	Efficacy	false		lithium
699639145	rs140504	PMID:21047205	BCR	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	not stated		161		East Asian	Efficacy	false	This is from a review article which does not give all the details.	lithium
1449144250	rs62200793	PMCID:PMC5833535	ZNF804A	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	yes	= 5.45E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
699639151	rs2284017	PMID:21047205	CACNG2	Genotype CC is associated with increased response to lithium in people with Bipolar Disorder.	not stated		383		European	Efficacy	false	This is from a review article which does not give all the details.	lithium
827816630	rs12693402	PMID:21961650	ZNF804A	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	no	= 0.53	204		Unknown	Efficacy	false	Patients were characterized as full responders compared to partial/non long-term responders. Quantitative trait analysis of long-term treatment response scale comparing all three genotypes also found no statistically significant association.	lithium
1449144194	rs324899	PMCID:PMC5833535		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 4.63E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
1183702122	rs17026688	PMID:24369049	GADL1	Allele T is associated with increased response to lithium when treated with lithium in people with Bipolar Disorder as compared to allele C.	yes	= 6.69e-62	394		East Asian	Efficacy	false		lithium
1449144201	rs6942227	PMCID:PMC5833535		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 8.45E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
827816637	rs2811332	PMID:21961650	TMCC1	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	no	= 0.1658	204		Unknown	Efficacy	false	Patients were characterized as full responders compared to partial/non long-term responders. Quantitative trait analysis of long-term treatment response scale comparing all three genotypes also found no association. Please note: the TMCC1 gene is found on the minus chromosomal strand - here we report alleles on the plus strand in a complementary manner from those reported in the study.	lithium
699639132	rs6265	PMID:21047205	BDNF; BDNF-AS	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	not stated		134		Multiple groups, Brazilian	Efficacy	false	This is from a review article which does not give all the details.  It says that no association was found between the SNP and lithium response, but it does not state exactly how the alleles were compared.	lithium
1449144207	rs1611259	PMCID:PMC5833535		Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	yes	= 9.92E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false	Please note that this SNP is given the ID rs142425863 in the paper.	lithium
1449144213	rs59724122	PMCID:PMC5833535	EPHX2	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	yes	= 7.21E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium
1451294582	rs2290910	PMID:32893730	ADCY2	Genotypes CC + CT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotype TT.	no		202			Efficacy	false	"Authors state ""frequencies of CC and CT genotypes were less than TT in the responder group compared with nonresponders which suggest the reference homozygote or heterozygote genotype of this variant as factors for predicting lithium carbonate response in bipolar patients"" and ""e frequency of patients with TT genotype was
0 in no responder group of patients, both responder versus nonresponder and responder versus semi responder
analyses were significant for TT compared with both CC and CT genotypes but OR numbers tend to be infinite
and could not be calculated."" Numbers of TT homozygotes were small (n=6, 3 were R and 3 were SR 0 were NR)."	lithium
827816621	rs11869731	PMID:21961650	ASIC2	Genotype CC is associated with increased response to lithium in people with Bipolar Disorder as compared to genotypes CG + GG.	yes	= 4.7E-4	204		Unknown	Efficacy	false	P value for quantitative trait analysis of long-term treatment response scale comparing all three genotypes. Please note: the ACCN1 gene is found on the minus chromosomal strand. The G allele was reported in this study as the minor allele - genotype GG was associated with response to lithium. Here we give the association with the complementary C allele on the plus chromosomal strand.	lithium
1449144219	rs61123830	PMCID:PMC5833535	GRAMD1B	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	yes	= 2.60E-3	2586		Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent	Efficacy	false		lithium